FY23 Revised Forecast by Segment
FY23 | FY23 | FY22 | Y on Y | |||||
Revised | Initial | Difference | ||||||
Results | Difference | |||||||
Forecast | Forecast | |||||||
Sales | 1,465.0 | 1,465.0 | 0.0 | 1,359.1 | 105.8 | |||
Seasonings and Foods | 852.8 | 823.8 | 29.0 | 775.0 | 77.8 | |||
Sauce | & Seasonings | 426.2 | 393.8 | 32.4 | 379.7 | 46.4 | ||
Quick Nourishment | 233.6 | 230.1 | 3.4 | 209.5 | 24.0 | |||
Solution & Ingredients (S&I) | 192.9 | 199.7 | -6.8 | 185.6 | 7.2 | |||
Frozen Foods | 291.4 | 292.3 | -0.9 | 267.2 | 24.1 | |||
Healthcare and Others | 302.2 | 330.1 | -27.9 | 299.6 | 2.5 | |||
Bio-Pharma Services & Ingredients | 139.8 | 140.3 | -0.4 | 129.5 | 10.2 | |||
Amino acids for | 57.5 | |||||||
pharmaceuticals and foods | ||||||||
Bio-Pharma Services | 72.0 | |||||||
(CDMO services) | ||||||||
Functional Materials | 60.0 | 81.2 | -21.1 | 70.1 | -10.0 | |||
(electronic materials and others) | ||||||||
Others | 102.3 | 108.6 | -6.2 | 99.9 | 2.3 | |||
Other | 18.5 | 18.6 | -0.0 | 17.1 | 1.3 | |||
Business Profit | 150.0 | 150.0 | 0.0 | 135.3 | 14.6 | |||
Seasonings and Foods | 105.7 | 92.9 | 12.7 | 84.8 | 20.9 | |||
Sauce | & Seasonings | 79.2 | 67.7 | 11.5 | 62.4 | 16.8 | ||
Quick Nourishment | 16.6 | 18.5 | -1.9 | 16.6 | -0.0 | |||
Solution & Ingredients (S&I) | 26.2 | 24.5 | 1.7 | 23.4 | 2.8 | |||
Shared companywide expenses | -16.6 | -18.0 | 1.4 | -17.1 | 0.4 | |||
Frozen Foods | 10.0 | 3.7 | 6.2 | 2.0 | 8.0 | |||
Frozen Foods | 14.8 | 9.0 | 5.8 | 7.0 | 7.8 | |||
Shared companywide expenses | -4.7 | -5.2 | 0.4 | -5.0 | 0.2 | |||
Healthcare and Others | 35.0 | 54.1 | -19.0 | 48.6 | -13.5 | |||
Bio-Pharma Services & Ingredients | 16.1 | 20.7 | -4.5 | 18.2 | -2.0 | |||
Functional Materials | 27.0 | 42.0 | -14.9 | 36.9 | -9.8 | |||
(electronic materials and others) | ||||||||
Others | 4.8 | 4.9 | -0.1 | 5.0 | -0.2 | |||
Shared companywide expenses | -12.9 | -13.5 | 0.5 | -11.5 | -1.4 | |||
Other | -0.8 | -0.8 | -0.0 | -0.1 | -0.7 | |||
Shared companywide expenses | -0.8 | -0.9 | 0.0 | -0.8 | 0.0 | |||
November 6, 2023
(Billion yen)
FY23/1H | FY22/1H | Y on Y | FY23/2H | FY22/2H | Y on Y | Reasons for Forecast Revision |
Results | Results | Difference | Forecast | Results | Difference | |
688.0 | 659.8 | 28.1 | 776.9 | 699.2 | 77.7 | Seasonings and Foods |
Sauce & Seasonings: | ||||||
Upward revision of revenue primarily due to increased sales overseas | ||||||
404.7 | 372.7 | 31.9 | 448.1 | 402.2 | 45.8 | and the impact of currency translation. |
Quick Nourishment: | ||||||
206.8 | 185.9 | 20.8 | 219.3 | 193.8 | 25.5 | Upward revision of revenue primarily due to the impact of currency |
translation overseas. | ||||||
Solution & Ingredients: | ||||||
103.6 | 93.8 | 9.7 | 129.9 | 115.6 | 14.3 | |
Downward revision of revenue primarily due to decreased sales of | ||||||
umami seasonings for processed food manufacturers. | ||||||
94.2 | 92.9 | 1.2 | 98.7 | 92.7 | 5.9 | |
Frozen Foods | ||||||
Downward revision of revenue due to decreased sales in Japan. | ||||||
136.5 | 128.5 | 7.9 | 154.8 | 138.6 | 16.2 | |
Healthcare and Others | ||||||
Bio-Pharma Services & Ingredients: | ||||||
139.5 | 151.6 | -12.1 | 162.6 | 148.0 | 14.6 | Downward revision of revenue due to decreased sales of amino acids |
for pharmaceuticals and foods. | ||||||
62.2 | 64.2 | -1.9 | 77.5 | 65.3 | 12.1 | Functional Materials (electronic materials and others) : |
Downward revision of revenue primarily due to decreased sales of | ||||||
26.5 | 30.0 | -3.4 | 27.5 | electronic materials. | ||
Others: | ||||||
35.5 | 34.0 | 1.4 | 37.5 | Overall downward revision. | ||
28.5 | 37.2 | -8.7 | 31.5 | 32.8 | -1.3 | |
48.7 | 50.1 | -1.4 | 53.5 | 49.7 | 3.7 | |
7.2 | 6.8 | 0.3 | 11.2 | 10.3 | 0.9 | |
76.5 | 74.3 | 2.2 | 73.4 | 61.0 | 12.4 | Seasonings and Foods |
Sauce & Seasonings: | ||||||
Upward revision of profit primarily due to increased sales overseas and | ||||||
57.1 | 44.0 | 13.1 | 48.5 | 40.7 | 7.7 | the impact of currency translation. |
Quick Nourishment: | ||||||
42.0 | 30.8 | 11.2 | 37.1 | 31.6 | 5.5 | Downward revision of profit primarily due to the impact of cost increases |
for coffee product raw materials in Japan. | ||||||
Solution & Ingredients: | ||||||
6.7 | 7.9 | -1.1 | 9.8 | 8.6 | 1.1 | |
Upward revision of profit primarily due to the impact of improving cost | ||||||
efficiency and the impact of currency translation. | ||||||
15.3 | 13.7 | 1.6 | 10.9 | 9.7 | 1.2 | |
Frozen Foods | ||||||
Upward revision of profit primarily due to structural reform overseas and | ||||||
-7.7 | -7.3 | -0.4 | -8.8 | -9.8 | 0.9 | the impact of currency translation. |
Healthcare and Others | ||||||
6.6 | 0.5 | 6.1 | 3.3 | 1.4 | 1.8 | Bio-Pharma Services & Ingredients: |
Downward revision of profit primarily due to decreased sales of amino | ||||||
8.8 | 2.5 | 6.3 | 5.9 | 4.4 | 1.5 | acids for pharmaceuticals and foods. |
Functional Materials (electronic materials and others) : | ||||||
-2.1 | -2.0 | -0.1 | -2.6 | -2.9 | 0.3 | Downward revision of profit primarily due to decreased sales of |
electronic materials. | ||||||
Others: | ||||||
10.9 | 28.8 | -17.9 | 24.1 | 19.7 | 4.3 | |
Overall on par with initial forecast. | ||||||
2.0 | 10.3 | -8.3 | 14.1 | 7.8 | 6.2 | |
12.2 | 20.0 | -7.8 | 14.8 | 16.8 | -2.0 | |
2.5 | 3.7 | -1.2 | 2.2 | 1.2 | 1.0 | |
-5.8 | -5.3 | -0.5 | -7.0 | -6.1 | -0.9 | |
1.7 | 0.9 | 0.8 | -2.6 | -1.0 | -1.6 | |
-0.2 | -0.3 | 0.1 | -0.6 | -0.5 | -0.0 | |
Business Profit : A profit indicator defined by Ajinomoto for administrative purposes
Sales - Cost of sales - Selling expenses, Research & development expenses and General & administrative expenses + Share of profit of associates and joint ventures
Starting in FY2023, the method for allocating shared expenses such as R&D expenses is changed in order to better evaluate the business performance of each reportable segment. The above figures, including results for FYFY2022, reflect this change.
Notes: Nondisclosure
(Italic) Approximation
(Reference) Revised Sales Forecast by Business & Geographical Area | (Billion yen) | |||||||||||||||
Japan | Asia | Americas | EMEA | Total | ||||||||||||
Sales | FY23 | FY22 | YoY | FY23 | FY22 | YoY | FY23 | FY22 | YoY | FY23 | FY22 | YoY | FY23 | FY22 | YoY | |
Forecast | Results | Change | Forecast | Results | Change | Forecast | Results | Change | Forecast | Results | Change | Forecast | Results | Change | ||
Seasonings and Foods | 295.3 | 274.0 | 21.2 | 385.2 | 338.2 | 47.0 | 124.5 | 110.4 | 14.1 | 47.6 | 52.2 | -4.6 | 852.8 | 775.0 | 77.8 | |
Frozen Foods | 92.0 | 89.7 | 2.2 | 5.4 | 4.7 | 0.6 | 171.8 | 155.1 | 16.7 | 22.1 | 17.6 | 4.5 | 291.4 | 267.2 | 24.1 | |
Healthcare and Others | 125.0 | 129.0 | -3.9 | 11.0 | 9.0 | 1.9 | 82.8 | 88.3 | -5.5 | 83.2 | 73.1 | 10.0 | 302.2 | 299.6 | 2.5 | |
Other | 17.9 | 17.1 | 0.8 | 0.3 | 0.0 | 0.2 | - | - | - | 0.0 | 0.0 | 0.0 | 18.5 | 17.1 | 1.3 | |
Total | 530.6 | 509.9 | 20.6 | 401.9 | 352.0 | 49.9 | 379.2 | 353.9 | 25.3 | 153.0 | 143.1 | 9.9 | 1,465.0 | 1,359.1 | 105.8 |
・Forward-looking statements, such as business performance forecasts, made in these materials are based on management's estimates, assumptions and projections at the time of publication and do not represent a commitment from Ajinomoto Co., Inc. that they will be achieved. A number of factors could cause actual results to differ materially from expectations.
・Unaudited figures are included in these materials for reference.
・Amounts presented in these materials are rounded down.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ajinomoto Co. Inc. published this content on 06 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 November 2023 06:22:08 UTC.